Baseline characteristics of 1461 participants in the Pulmonary Fibrosis Foundation Patient Registry
K. Flaherty (Ann Arbor , United States of America), J. De Andrade (Birmingham, United States of America), L. Lancaster (Nashville, United States of America), S. Limb (South San Francisco, United States of America), K. Lindell (Pittsburgh, United States of America), S. Nathan (Falls Church, United States of America), G. Raghu (Seattle, United States of America), C. Spino (Ann Arbor , United States of America), J. Stauffer (South San Francisco, United States of America), P. Wolters (San Francisco, United States of America), G. Cosgrove (Chicago, United States of America)
Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Flaherty (Ann Arbor , United States of America), J. De Andrade (Birmingham, United States of America), L. Lancaster (Nashville, United States of America), S. Limb (South San Francisco, United States of America), K. Lindell (Pittsburgh, United States of America), S. Nathan (Falls Church, United States of America), G. Raghu (Seattle, United States of America), C. Spino (Ann Arbor , United States of America), J. Stauffer (South San Francisco, United States of America), P. Wolters (San Francisco, United States of America), G. Cosgrove (Chicago, United States of America). Baseline characteristics of 1461 participants in the Pulmonary Fibrosis Foundation Patient Registry. 2199
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: